SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-036948
Filing Date
2020-08-05
Accepted
2020-08-05 17:23:37
Documents
43
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcon-10q_20200630.htm 10-Q 1659296
2 EX-31.1 tcon-ex311_6.htm EX-31.1 9263
3 EX-32.1 tcon-ex321_7.htm EX-32.1 5632
  Complete submission text file 0001564590-20-036948.txt   4796095

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT tcon-20200630.xml EX-101.INS 789642
5 XBRL TAXONOMY EXTENSION SCHEMA tcon-20200630.xsd EX-101.SCH 46192
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tcon-20200630_cal.xml EX-101.CAL 32163
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tcon-20200630_def.xml EX-101.DEF 127111
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20200630_lab.xml EX-101.LAB 308890
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20200630_pre.xml EX-101.PRE 219710
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36818 | Film No.: 201078680
SIC: 2836 Biological Products, (No Diagnostic Substances)